Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12221473 | Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof | Bridget Puffer, Julian Chandler, Nimish Gera, Douglas L. Sheridan, Siddharth Jindal | 2025-02-11 |
| 11498960 | Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof | Bridget Puffer, Julian Chandler, Nimish Gera, Douglas L. Sheridan, Siddharth Jindal | 2022-11-15 |
| 11434280 | Anti-C5 antibodies having improved pharmacokinetics | Bruce A. Andrien, Jr., Douglas L. Sheridan, Yi Wang | 2022-09-06 |
| 11407821 | Anti-C5A antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2022-08-09 |
| 11198725 | Monovalent anti-properdin antibodies and antibody fragments | Douglas L. Sheridan, Taneisha Ann-Tanara MACK, Walter C. Voegtli | 2021-12-14 |
| 10584164 | Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria with anti-C5 antibodies | Bruce A. Andrien, Jr., Douglas L. Sheridan, Yi Wang | 2020-03-10 |
| 10450370 | Anti-C5a antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2019-10-22 |
| 10227400 | Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies | Bruce A. Andrien, Jr., Douglas L. Sheridan, Yi Wang | 2019-03-12 |
| 9963503 | Methods of producing anti-C5a antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2018-05-08 |
| 9803007 | Anti-C5 antibodies having improved pharmacokinetics | Bruce A. Andrien, Jr., Douglas L. Sheridan, Yi Wang | 2017-10-31 |
| 9663574 | Anti-C5 antibodies having improved pharmacokinetics | Bruce A. Andrien, Jr., Douglas L. Sheridan, Yi Wang | 2017-05-30 |
| 9469690 | Methods of treating complement-associated disorders with anti-C5a antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2016-10-18 |
| 9434784 | Nucleic acids encodng anti-C5A antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2016-09-06 |
| 9371377 | Anti-C5 antibodies having improved pharmacokinetics | Bruce A. Andrien, Jr., Douglas L. Sheridan | 2016-06-21 |
| 9371378 | Anti-C5a antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2016-06-21 |
| 9309310 | Nucleic acids encoding anti-C5a antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2016-04-12 |
| 9221901 | Methods of treating complement-associated disorders with anti-C5a antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2015-12-29 |
| 9206251 | Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics | Bruce A. Andrien, Jr., Douglas L. Sheridan | 2015-12-08 |
| 9107861 | Methods of treating C5 mediated complement-associated conditions with anti-C5 antibodies having improved pharmacokinetics | Bruce A. Andrien, Jr., Douglas L. Sheridan | 2015-08-18 |
| 9079949 | Anti-C5 antibodies having improved pharmacokinetics | Bruce A. Andrien, Jr., Douglas L. Sheridan | 2015-07-14 |
| 9011852 | Anti-C5a antibodies | Russell P. Rother, Douglas L. Sheridan, Yuchun Zhang | 2015-04-21 |
| 8168758 | Anti-MN antibodies and methods of using same | Gerald Ranges, Lila Adnane, Timothy McCabe, Pamela Trail, Sha Ha | 2012-05-01 |
| 7452859 | Human bikunin | Gary Davis, Katherine Delaria, Christopher W. Marlor, Daniel K. Muller | 2008-11-18 |
| 7019123 | Human bikunin | Gary Davis, Katherine Delaria, Christopher W. Marlor, Daniel K. Muller | 2006-03-28 |
| 6583108 | Human bikunin | Gary Davis, Katherine Delaria, Christopher W. Marlor, Daniel K. Muller | 2003-06-24 |